Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05358548
Title ATATcH Alternating Treatment Plans for Advanced Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Rutgers, The State University of New Jersey
Indications

lung non-squamous non-small cell carcinoma

hypopharynx cancer

lung non-small cell carcinoma

oral cavity cancer

oropharynx cancer

laryngeal squamous cell carcinoma

lung squamous cell carcinoma

head and neck squamous cell carcinoma

Therapies

Carboplatin + Paclitaxel + Pembrolizumab

Carboplatin + Pembrolizumab + Pemetrexed Disodium

Carboplatin + Fluorouracil + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST